Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kent

Showing results (981-990 of 1,017) with videos related to

Pageof 102
Sort By:
Nucleic Acids Research|December 31, 2005
The UCSC Genome Browser Database: update 2006A S Hinrichs, D Karolchik, R Baertsch, et al.
The Journal of Infectious Diseases|July 2, 2025
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination TrialVictoria G Hall, Thi H O Nguyen, Olivia C Smibert, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Cell Reports|February 10, 2021
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humansHenry J Sutton, Racheal Aye, Azza H Idris, et al.
Plos Pathogens|October 12, 2012
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infectionBrian R Amman, Serena A Carroll, Zachary D Reed, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2021
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect micePhillip Pymm, Amy Adair, Li-Jin Chan, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Pageof 102

Showing results (981-990 of 1,017) with videos related to

Sort By:
Pageof 102
Nucleic Acids Research|December 31, 2005
The UCSC Genome Browser Database: update 2006A S Hinrichs, D Karolchik, R Baertsch, et al.
The Journal of Infectious Diseases|July 2, 2025
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination TrialVictoria G Hall, Thi H O Nguyen, Olivia C Smibert, et al.
Science Translational Medicine|April 1, 2026
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B virusesThi H O Nguyen, Isabelle J H Foo, Ruth A Purcell, et al.
Cell Reports|February 10, 2021
Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humansHenry J Sutton, Racheal Aye, Azza H Idris, et al.
Plos Pathogens|October 12, 2012
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infectionBrian R Amman, Serena A Carroll, Zachary D Reed, et al.
Nature Communications|June 5, 2026
Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidityMorgan J Skinner, Lukasz Kedzierski, Ruth A Purcell, et al.
The Lancet. Gastroenterology & Hepatology|February 6, 2022
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control studyJames L Alexander, Nicholas A Kennedy, Hajir Ibraheim, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2021
Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous AustraliansLuca Hensen, Thi H O Nguyen, Louise C Rowntree, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2021
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect micePhillip Pymm, Amy Adair, Li-Jin Chan, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Pageof 102